Neurosteroid modulation of N-methyl-d-aspartate receptors: Molecular mechanism and behavioral effects

  title={Neurosteroid modulation of N-methyl-d-aspartate receptors: Molecular mechanism and behavioral effects},
  author={Miloslav Korinek and Vojtěch Kapras and Vojtech Vyklicky and Eva Adamusova and Jiřina Borovsk{\'a} and Karel Vale{\vs} and Ales Stuchlik and Martin Horak and Hana Chodounsk{\'a} and Ladislav Vyklick{\'y}},

Figures and Tables from this paper

Block of NMDA receptor channels by endogenous neurosteroids: implications for the agonist induced conformational states of the channel vestibule

The molecular basis of the use-dependent and voltage-independent inhibitory effect of neurosteroids on NMDAR responses is identified and structure details of the open configuration of the N MDAR channel are characterized.

A New Class of Potent N-Methyl-D-Aspartate Receptor Inhibitors: Sulfated Neuroactive Steroids with Lipophilic D-Ring Modifications.

There is a strong correlation between this new structural feature and the in vitro activity, as all tested compounds were evaluated as more potent inhibitors of NMDA-induced currents than the known endogeneous neurosteroid-pregnanolone sulfate.

Pregnenolone sulfate as a modulator of synaptic plasticity

PregS likely plays a significant role in modulation of glutamatergic excitatory synaptic transmission underlying learning and memory, yet the molecular target(s) for its action awaits identification.

NMDAR PAMs: Multiple Chemotypes for Multiple Binding Sites.

  • P. Goldsmith
  • Biology
    Current topics in medicinal chemistry
  • 2019
Research on NMDARs continues to provide novel mechanistic insights into receptor activation and this review will provide a high-level overview of the research area and discuss the various chemical classes of PAMs discovered so far.

Pregnanolone Glutamate, a Novel Use-Dependent NMDA Receptor Inhibitor, Exerts Antidepressant-Like Properties in Animal Models

3α5β-pregnanolone glutamate (PG) is a use-dependent antagonist of NMDA receptors and showed antidepressant-like and anxiolytic-like properties in the used tests, with minimal side-effects.

Neurosteroids in Schizophrenia: Pathogenic and Therapeutic Implications

The content regarding the modulation of the GABAA receptor is elaborated, given the considerable knowledge of its interactions with other neurotransmitter and neuroprotective systems, as well as its ameliorating effects on stress that may play a role in the SZ pathophysiology.

Neurosteroid Actions in Memory and Neurologic/Neuropsychiatric Disorders

The effects of both endogenously active and exogenously administered neurosteroids on neural networks across the life span of women and men point to a possible underlying pharmacological connectome by which these neuromodulators might act to modulate memory across diverse altered states of mind.

Effect of developmental NMDAR antagonism with CGP 39551 on aspartame-induced hypothalamic and adrenal gene expression

ASP exposure robustly elevated the expression of a network of genes involved in hypothalamic neurosteroidogenesis, together with cell stress and inflammatory genes, consistent with previous reports of aspartame-induced CNS stress and oxidative damage.



Pregnenolone sulfate: a positive allosteric modulator at the N-methyl-D-aspartate receptor.

Pregnenolone sulfate specifically enhances NMDA-gated currents in spinal cord neurons, while inhibiting receptors for the inhibitory amino acids glycine and gamma-aminobutyric acid, as well as non-NMDA glutamate receptors, consistent with the hypothesis that neurosteroids such as pregnenol one sulfate are involved in regulating the balance between excitation and inhibition in the central nervous system.

Neuroprotective activity of a new class of steroidal inhibitors of the N-methyl-D-aspartate receptor.

The in vitro and in vivo neuroprotective effects of 3alpha5betaHS demonstrate that this steroid represents a new class of potentially useful therapeutic agents for the treatment of stroke and certain neurodegenerative diseases that involve over activation of NMDA receptors.

Molecular Mechanisms for Nanomolar Concentrations of Neurosteroids at NR1/NR2B Receptors

Results substantiate previous evidence of the allosteric modulatory effect induced by PS and 3α5βS on NMDA receptors at nanomolar concentrations and are reflected in an altered glutamate stimulated [Ca2+]i, in response to ifenprodil.

Pregnenolone sulfate potentiation of N-methyl-D-aspartate receptor channels in hippocampal neurons.

The fractional open time (nPo) of single NMDA-activated channels was potentiated by PS in patch-clamp recordings using both the outside-out and cell-attached configurations, and the potentiation resulted from increases in the frequency of opening and in the mean channel open time.

Molecular Mechanism of Pregnenolone Sulfate Action at NR1/NR2B Receptors

The results suggest that the PS is a modulator of NMDA receptor Po, the effectiveness of which is lowered by glutamate binding, which may have important consequences for the neuronal excitability.

Pregnanolone Sulfate Promotes Desensitization of Activated NMDA Receptors

It is proposed that PAS inhibits NMDA receptor activity by shifting active receptors into desensitized conformations, highlighting the neurosteroid inhibitory site on NMDA receptors as a valuable therapeutic target against excitotoxic pathologies including acute and chronic neurodegeneration.